Europe
Two artificial intelligence (AI) companies, Biorelate Limited and Intellegens Limited, announced their success in the third round of the Innovate UK open grant funding competition.
NOXXON Pharma N.V., a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment, published a shareholder letter addressing recent clinical data and outlining its corporate strategy going forward.
Recipharm will publish its full year report for January – December 2018 on 21 February at 7:45 am CET.
Study Found Greater Than 40 Percent of Patients on Hospital General Care Floor Experience Opioid- Induced Respiratory Depression
Mumbai-based Glenmark Pharmaceuticals is spinning off its innovation business into a standalone company based in the United States. The new business will have its own chief executive officer and board of directors.
Immunicum announced a collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate ilixadencel in combination with Avelumab in multi-indication phase Ib/II study ILIAD.
MDxHealth SA announced that positive data and observations from multiple studies and patient registries demonstrating the value of SelectMDx and ConfirmMDx for Prostate Cancer diagnosis, will be presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place in San Francisco, California, February 14-16, 2019.
Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.
As the American Society of Clinical Oncology 2019 Genitourinary Cancers Symposium (ASCO GU) rolls on, companies are showcasing more data in presentations. BioSpace takes a look at some of the latest.
LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology
LenioBio GmbH announces the appointment of Dr. Lorenz M. Mayr, Prof. Govind Rao, and Prof. Stefan Schillberg to LenioBio’s Scientific Advisory Board (SAB).
PRESS RELEASES